Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 502 participants.
Also called NCT04661709
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 502 participants
- Sponsor
- Registry
-
NCT04661709
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04661709. Randomized; triple masking; primary purpose treatment. Start 2021-03-01 (anticipated); primary completion 2023-03-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris
- Condition
- Coronary Heart Disease
- Condition
- Unstable Angina
- Condition
- Chinese Herbal Medicine
- Intervention (Drug)
- Wen Xin granule
- Intervention (Drug)
- Clopidogrel Hydrogen Sulfate 75 MG Oral Tablet
- Intervention (Drug)
- Atorvastatin Calcium
- Intervention (Drug)
- Isosorbide Mononitrate Tab 20 MG
- Intervention (Drug)
- Metoprolol Tartrate Tab 25 MG
- Intervention (Drug)
- Aspirin Enteric-coated Tablets
- Intervention (Drug)
- WXG placebo
- Intervention (Drug)
- Trimetazidine Dihydrochloride Tablets
- Intervention (Drug)
- glyceryl trinitrate
- Lead sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Collaborator
- Special Project of National Traditional Chinese Medicine Clinical Research Base of State Administration of Traditional Chinese Medicine
- Collaborator
- National Natural Science Foundation of China
Record details
- Record id
cardio:ct-nct04661709- Content hash
e96133f7c1d484be78217d1b3a989264f80c277a2f8d2b9eddaf2bd7dd5dcc7f